Literature DB >> 8279010

Prolonged preservation in University of Wisconsin solution associated with hepatic artery thrombosis after orthotopic liver transplantation.

E Mor1, M E Schwartz, P A Sheiner, P Menesses, P Hytiroglou, S Emre, K Kishikawa, S Chiodini, C M Miller.   

Abstract

Hepatic artery thrombosis (HAT) after liver transplantation (LTx) usually mandates retransplantation. Prolonged preservation with Eurocollins solution has been associated with HAT. We reviewed our experience with 359 LTx patients to identify risk factors for HAT. All grafts were preserved in University of Wisconsin solution. HAT developed in 12 patients (3%) within 50 days. Seven patients were asymptomatic; four presented with biliary sepsis and 1 with poor graft function. Two patients had suffered acute rejection; another 2 had severe preservation injury. Technical problems accounted for 4 cases; in the remaining 8, no etiology was found. Diagnosis was at a mean 14.7 days after LTx. One patient maintains normal graft function 3 years after LTx without intervention. Eight underwent re-LTx, 3 of whom died. Routine surveillance via duplex enabled early diagnosis and revascularization in 3 patients; in all 3, no biliary complications occurred between 6 and 20 months. Overall graft and patient survival after HAT were 33.3% and 75%, respectively. Cold ischemic time (CIT) averaged 813 min in patients with HAT and 669 min in those without HAT (P < .05). HAT occurred in 7/165 patients with CIT > 12 hr, and in 3/234 patients with CIT < 12 hr (P = 0.0699). By avoiding CIT > 12 hr, we have recently avoided HAT in 78 consecutive patients. We conclude that CIT > 12 hr may increase the risk of HAT. When HAT is diagnosed before biliary sepsis develops, flow can often be restored and retransplantation averted.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8279010     DOI: 10.1097/00007890-199312000-00024

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

Review 1.  Split-liver transplantation. The Paul Brousse policy.

Authors:  D Azoulay; I Astarcioglu; H Bismuth; D Castaing; P Majno; R Adam; M Johann
Journal:  Ann Surg       Date:  1996-12       Impact factor: 12.969

2.  Split-liver transplantation for two adult recipients: feasibility and long-term outcomes.

Authors:  D Azoulay; D Castaing; R Adam; E Savier; V Delvart; V Karam; B Y Ming; M Dannaoui; J Krissat; H Bismuth
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

3.  Polyethylene glycol rinse solution: an effective way to prevent ischemia-reperfusion injury.

Authors:  Mohamed Amine Zaouali; Mohamed Bejaoui; Maria Calvo; Emma Folch-Puy; Eirini Pantazi; Gianfranco Pasut; Antoni Rimola; Hassen Ben Abdennebi; René Adam; Joan Roselló-Catafau
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

4.  Orthotopic liver transplantation for congenital biliary atresia. An 11-year, single-center experience.

Authors:  J A Goss; C R Shackleton; K Swenson; N L Satou; B J Nuesse; D K Imagawa; M M Kinkhabwala; P Seu; J S Markowitz; S M Rudich; S V McDiarmid; R W Busuttil
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

5.  Superior Outcomes and Reduced Wait Times in Pediatric Recipients of Living Donor Liver Transplantation.

Authors:  Mohit Kehar; Rulan S Parekh; Jennifer Stunguris; Maria De Angelis; Krista Van Roestel; Anand Ghanekar; Mark Cattral; Annie Fecteau; Simon Ling; Binita M Kamath; Nicola Jones; Yaron Avitzur; David Grant; Vicky Lee Ng
Journal:  Transplant Direct       Date:  2019-02-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.